David J. Arthur, Chief Executive Officer at Salarius Pharmaceuticals, Inc. (SLRX), bought 43,900 shares at $0.18 ($8K) on 2022-05-26, disclosed to the SEC on 2022-05-31.
Open-market purchase of $8k SLRX by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.18 | 708 | $127 | 1.6% |
| 2 | $0.18 | 3,400 | $612 | 7.7% |
| 3 | $0.18 | 10,392 | $2K | 23.7% |
| 4 | $0.18 | 10,800 | $2K | 24.6% |
| 5 | $0.18 | 18,600 | $3K | 42.4% |
| Total | $0.18 avg | 43,900 |
| $8K |
| 100% |
| Filing → |
| SLRX | BUY | 2020-08-20 | $1K | — | Filing → |
| SLRX | BUY | 2020-02-12 | $3K | — | Filing → |